DKmed
Timeline
9 events since 2023Filings
Financial
Establishments
Address
2023202420252026
Deadline for the 2026 accounts: 31-07-2027
2026
Annual accounts 2025 filed PDFmicro format · 81 days before the deadline
2025
Highest result from 2023 to 2025 net €98,116 ▲106% The operating result of €125,021 and the net result of €98,116 are both a record.
Equity above €150,000 equity €156,834 ▲167% With a profit in every financial year since 2023, equity grows to €156,834.
Registered in the Peppol Directory Reachable for e-invoices through 0208:1002868647
Annual accounts 2024 filed PDFmicro format · 29 days late
Registered office moved from Izegem to KortrijkNew registered office: Morgenzon 11, 8500 Kortrijk · Previous registered office: Meensesteenweg 77, 8870 Izegem · Board meeting of 14-04-20252 points ▸
- Board meeting, 14-04-2025
- Registered-office move, Morgenzon 11, 8500 Kortrijk
2024
Annual accounts 2023 filed PDFmicro format · 27 days before the deadline
2023
IncorporationAppointment: DEWULF, Karel Pierre Thérèse (director) · Founder: DEWULF, Karel Pierre Thérèse · Founding capital of €6,000, 120 shares · published on 05-12-20234 points ▸
- Founder, DEWULF, Karel Pierre Thérèse
- Founding capital, €6,000, 120 shares
- Registered office clause, Meensesteenweg 77, 8870 Izegem
- Director appointment, DEWULF, Karel Pierre Thérèse (director (not named in the articles))
- The deed holds 4 more points.
First establishment Morgenzon 11, Kortrijk
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank
History
On 30 November 2023, DKmed was incorporated as a private limited company by one natural person, with a starting capital of €6,000.12 In 2025 the registered office moved to Kortrijk.3 DEWULF,Karel Pierre Thérèse has served as director since 2025.4 Total assets went from €16,288 in 2023 to €188,038 in 2025.5